UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign

Clinical infectious diseases, 2007-02, Vol.44 (3), p.373-379

2007

Volltextzugriff (PDF)

Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised Patients

Clinical infectious diseases, 2003-09, Vol.37 (5), p.728-732

2003

Volltextzugriff (PDF)

The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis

Infection, 2011-06, Vol.39 (3), p.201-210

2011

Volltextzugriff (PDF)

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.819-826

2006

Volltextzugriff (PDF)

Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis

Clinical microbiology and infection, 2020-06, Vol.26 (6), p.781.e1-781.e8

2020

Volltextzugriff (PDF)

A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

Clinical infectious diseases, 2001-11, Vol.33 (9), p.1447-1454

2001

Volltextzugriff (PDF)

Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome

Clinical infectious diseases, 2005-11, Vol.41 (10), p.1448-1452

2005

Volltextzugriff (PDF)

Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS

AIDS (London), 1998-11, Vol.12 (16), p.2227-2228

1998

Volltextzugriff (PDF)

The efficacy of voriconazole in 24 ocular Fusarium infections

Infection, 2013-02, Vol.41 (1), p.15-20

2013

Volltextzugriff (PDF)

Fluconazole resistance in Candida glabrata

Antimicrobial Agents and Chemotherapy, 1993-09, Vol.37 (9), p.1962-1965

1993

Volltextzugriff (PDF)

Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (3), p.352-361

2005

Volltextzugriff (PDF)

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B

Antimicrobial Agents and Chemotherapy, 1995-03, Vol.39 (3), p.598-601

1995

Volltextzugriff (PDF)

Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities

Journal of clinical pharmacology, 2006-02, Vol.46 (2), p.235-243

2006

Volltextzugriff (PDF)

968 GENOTYPIC CHARACTERISATION OF HCV NS5B FOLLOWING 8-DAY MONOTHERAPY WITH THE POLYMERASE INHIBITOR PF-00868554 IN HCV-INFECTED SUBJECTS

Journal of hepatology, 2009, Vol.50, p.S351-S351

2009

Volltextzugriff (PDF)

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

Blood, 2005-10, Vol.106 (8), p.2641-2645

2005

Volltextzugriff (PDF)

Association of Mannose-Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients

Clinical infectious diseases, 2009-11, Vol.49 (10), p.1486-1491

2009

Volltextzugriff (PDF)

HepCARE: A tool enabling the identification, assessment and management of viral hepatitis. An integrated approach to the patient journey

Journal of hepatology, 2018-04, Vol.68, p.S174-S175

2018

Volltextzugriff (PDF)

THU-106 - HepCARE: A tool enabling the identification, assessment and management of viral hepatitis. An integrated approach to the patient journey

Journal of hepatology, 2018-04, Vol.68, p.S174-S175

2018

Volltextzugriff (PDF)

Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.616-620

2008

Volltextzugriff (PDF)

Improvement in the outcome of invasive fusariosis in the last decade

Clinical microbiology and infection, 2014-06, Vol.20 (6), p.580-585

2014

Volltextzugriff (PDF)

Breast cancer demographics, screening and survival outcome at a regional Australian cancer centre: a retrospective study

Annals of oncology, 2016-10, Vol.27, p.vi479-vi479

2016

Volltextzugriff (PDF)

An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity

Journal of antimicrobial chemotherapy, 2013-07, Vol.68 (7), p.1655-1659

2013

Volltextzugriff (PDF)

Standardized susceptibility testing of fluconazole: an international collaborative study

Antimicrobial Agents and Chemotherapy, 1992-09, Vol.36 (9), p.1805-1809

1992

Volltextzugriff (PDF)

Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients

Journal of antimicrobial chemotherapy, 2010-01, Vol.65 (1), p.107-113

2010

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(100)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(56)
Humans
(40)
Biological And Medical Sciences
(31)
Microbiology
(30)
Female
(29)
Medical Sciences
(28)
Animals
(25)
Infectious Diseases
(23)
Male
(23)
Pharmacology. Drug Treatments
(22)
Antifungal Agents - Therapeutic Use
(21)
Adult
(19)
Middle Aged
(19)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(18)
Pharmacology & Pharmacy
(18)
Voriconazole
(17)
Aged
(16)
Immunology
(16)
Antifungal Agents
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign

Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised Patients

The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis

A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome

Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS

The efficacy of voriconazole in 24 ocular Fusarium infections

Fluconazole resistance in Candida glabrata

Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B

Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities

968 GENOTYPIC CHARACTERISATION OF HCV NS5B FOLLOWING 8-DAY MONOTHERAPY WITH THE POLYMERASE INHIBITOR PF-00868554 IN HCV-INFECTED SUBJECTS

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

Association of Mannose-Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients

HepCARE: A tool enabling the identification, assessment and management of viral hepatitis. An integrated approach to the patient journey

THU-106 - HepCARE: A tool enabling the identification, assessment and management of viral hepatitis. An integrated approach to the patient journey

Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies

Improvement in the outcome of invasive fusariosis in the last decade

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

Breast cancer demographics, screening and survival outcome at a regional Australian cancer centre: a retrospective study

An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity

Standardized susceptibility testing of fluconazole: an international collaborative study

Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients

Suchergebnisse filtern